Abstract
An hPepT1-GFP fusion construct was made to study drug inhibition of dipeptide uptake and apical, basolateral, or subcellular hPepT1 localization. The hPepT1 stop codon was mutated by polymerase chain reaction and was subsequently cloned into the pEGFP-N1 vector. The hPepT1-GFP fusion construct was then transfected into Caco-2 and HeLa cells, and drug inhibition was studied by inhibiting 3H-Gly-Sar uptake. Western blot analysis was used to determine hPepT1-GFP expression levels and confocal microscopy was used to examine the localization. Both anti-hPepT1 antibody and anti-GFP antibody recognized a 120kd hPepT1-GFP fusion protein in the transfected cells. The 3H-Gly-Sar uptake in transfected HeLa cells was enhanced more than 20 times compared with the control. Valacyclovir (5 mmol/L) was able to completely inhibit 3H-Gly-Sar uptake in these transfected cells. Confocal microscopy showed that the hPepT1-GFP mainly localized in the Caco-2 cell apical membrane, but was present throughout the entire HeLa cell membranes. The hPepT1-GFP fusion protein was not found in either early endosome or lysosome of Caco-2 cells under normal conditions; however, it was detected in some subsets of lysosomes and early endosomes in phorbol 12-myristate 13-acetate (PMA)-treated Caco-2 cells.
Similar content being viewed by others
References
Amidon GL, Lee HJ. Absorption of peptide and peptidomimetic drugs. Annu Rev Pharmacol Toxicol. 1994;34:321–341.
Temple CS, Stewart AK, Meredith D, et al. Peptide mimics as substrates for the intestinal peptide transporter. J Biol Chem. 1998;273:20–22.
Liang R, Fei YJ, Prasad PD, et al. Human intestinal H+/peptide cotransporter: cloning functional expression, and chromosomal localization. J Biol Chem. 1995;270:6456–6463.
Shen H, Smith DE, Yang T, Huang YG, Schnermann JB, Brosius FC 3rd. Localization of PEPT1 and PEPT2 proton-coupled oligopeptide transporter mRNA and protein in rat kidney. Am J Physiol. 1999;276(5 Pt 2): F658-F665.
Ogihara H, Suzuki T, Nagamachi Y., Inui K, Takata K. Peptide transporter in the rat small intestine. Ultrastmctural localization and the effect of starvation and administration of ammo acids. Histochem J 1999;31(3):169–174.
Erickson RH, Gum JR Jr., Lindstrom MM, McKean D, Kim YS. Regional expression and dietary regulation of rat small intestimal peptide and amino acid transporter mRNAs. Biochem Biophys Res Commun. 1995;216:249–257.
Sadee W, Drubbisch V, Amidon GL. Biology of membrane transport proteins. Pharm Res. 1995;12(12):1823–1837.
Covitz KM, Amidon GL, Sadee W. Membrane topology of the human dipeptide transporter. hPEPT1, determined by epitope msertions. Biochemistry 1998;37:15214–15221.
Bai JP, Amidon GL. Structural specificity of mucosal-cell transport and metabolism of peptide drugs implication for oral peptide drug delivery. Pharm Res. 1992;9:969–978.
Han HK, Oh DM, Amidon GL Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter. Pharm Res. 1998;15:1382–1386.
Han H, de Vrueh RL, Rhie JK, et al. 5′-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter. Pharm Res. 1998;15:1154–1159.
Hsu CP, Hilfinger JM, Walter E, Merkle HP, Roessler BJ, Amidon GL. Overexpression of human intestinal oligopeptide transporter in mammalian cells via adenoviral transduction. Pharm Res. 1998;15:1376–1381.
Daniels GM, Amara SG. Regulated trafficking of the human dopamine transporter clathrin-mediated internalization and lysosomal degradation in response to phorbol esters. J Biol Chem. 1999;274:35794–35801.
Thamotharan M, Lombardo YB, Bawani SZ, Adibi SA. An active mechanism for completion of the final stage of protein degradation in the liver, lysosomal transport of dipeptides. J Biol Chem. 1997;272:11786–11790.
Isenman LD, Dice JF. Selective release of peptides from lysosomes. J Biol Chem. 1993;268:23856–23859.
Bird, SJ, Lloyd JB. Evidence for a dipeptide porter in the lysosome membrane. Biochim Biophys Acta. 1990;1024:267–270.
Lee VH, Chu C, Mahlin ED, et al. Biopharmaceutics of transmucosal peptide and protein drug administration: role of transport mechanisms with a focus on the involvement of Pep T1. J Control Release. 1999;62:129–140.
Mellman I. Endocytosis and molecular sorting. Ann Rev Cell Dev Biol. 1996;12:575–625.
Bucci C, Thomsen P, Nicoziani P, McCarthy J, van Deurs B. Rab7: akey to lysosome biogenesis. Mol Biol Cell 2000;11(2):467–480.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published: January 11, 2001.
Rights and permissions
About this article
Cite this article
Sun, D., Landowski, C.P., Chu, X. et al. Drug inhibition of Gly-Sar uptake and hPepT1 localization using hPepT1-GFP fusion protein. AAPS PharmSci 3, 2 (2001). https://doi.org/10.1208/ps030102
Received:
Accepted:
Published:
DOI: https://doi.org/10.1208/ps030102